fusidic acid has been researched along with Koch's Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Chibale, K; Dziwornu, GA; Kaur, G; Okombo, J; Shanika, PS; Singh, K | 1 |
| Akinpelu, OI; Kumalo, HM; Lawal, MM; Mhlongo, NN | 1 |
| Chibale, K; Dziwornu, GA; Mabhula, A; Singh, V | 1 |
| Chibale, K; Kigondu, EM; Warner, DF; Wasuna, A | 1 |
| JENNINGS, MA | 1 |
| Kronvall, G | 1 |
| Eykyn, SJ; Phillips, I | 1 |
2 review(s) available for fusidic acid and Koch's Disease
| Article | Year |
|---|---|
Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Discovery; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2014 |
Advances in antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicins; Humans; Infant; Infections; Lincomycin; Nalidixic Acid; Penicillin Resistance; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Sulfamethoxazole; Tuberculosis; Urinary Tract Infections | 1969 |
5 other study(ies) available for fusidic acid and Koch's Disease
| Article | Year |
|---|---|
Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity.
Topics: Animals; Anti-Bacterial Agents; Cricetulus; Drug Evaluation, Preclinical; Drug Repositioning; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium; Structure-Activity Relationship; Tuberculosis | 2020 |
Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
Topics: Antitubercular Agents; Bacterial Proteins; Binding Sites; Cytoskeletal Proteins; Density Functional Theory; Drug Repositioning; Fusidic Acid; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Molecular Targeted Therapy; Mutation; Mycobacterium tuberculosis; Protein Binding; Structure-Activity Relationship; Tuberculosis | 2020 |
Rv0684/
Topics: Antitubercular Agents; Fusidic Acid; Genes, Essential; Humans; Mycobacterium tuberculosis; Tuberculosis | 2021 |
Activity of helvolic acid against Mycobacterium tuberculosis.
Topics: Fusidic Acid; Humans; Mycobacterium tuberculosis; Tuberculosis | 1945 |
MIC determination of fusidic acid and of ciprofloxacin using multidisk diffusion tests.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fusidic Acid; Gram-Negative Bacteria; Gram-Positive Bacteria; Immunodiffusion; Microbial Sensitivity Tests; Pneumonia, Bacterial; Regression Analysis; Staphylococcus aureus; Staphylococcus epidermidis; Tuberculosis | 2000 |